Netherlands In-vitro Diagnostics Market by Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Others) Products (Reagents, Instruments, and Others), Usability (Reusable IVD Devices and Disposable IVD Devices), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Autoimmune Disease, and Others), End-users (Hospitals and Clinics, Diagnostics Laboratories, and Others) and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The Netherlands in-vitro diagnostics market size is expected register a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the growing population and increase in incidences of infectious and chronic diseases which requires number of in vitro diagnostics test.
In vitro diagnostic are test which detects the infections, conditions, and diseases to help, cure and prevent from diseases. It demands for reagents and assays for diagnosing a medical condition. It analyzes body fluids and tissue sample that can be collected through a patient. The tests can be conducted in health care facilities, laboratories or even in home. It consists of next generation sequencing test that scans a person’s DNA to find genomic variations.
In vitro diagnostics requires technical expertise for performing function hence it is used in specialized medical facilities to carry out diagnosis. Covid-19 impacted the Netherlands in vitro diagnostics market. In vitro diagnostics are used to check basic body functions which were not urgently required during the lockdown. Launch of in vitro diagnostics for covid-19 positively impacted the Netherlands in vitro diagnostic market.
Market Trends, Drivers, Restraints, and Opportunities
- Rising in use of personalized medicines for various treatments is estimated to propel the market expansion in the coming years.
- Development of automated in vitro diagnostic system for hospitals and laboratories is estimated to spur the market.
- Stringent government regulation and policies is projected to impede the market in the coming years.
- High price of in vitro diagnostics test product act as major factor that can hinder the market during the forecast period.
- R&D investment and technological advancement in vitro diagnostics is anticipated to create immense opportunities for the market players.
Scope of the Report
The report on the Netherlands in-vitro diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Netherlands In-vitro Diagnostics Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Test Types (Clinical Chemistry, Haematology, Immuno Diagnostics, Molecular Diagnostics, and Others) Products (Reagents, Instruments, and Others), Usability (Reusable IVD Devices and Disposable IVD Devices), Applications (Cardiology, Diabetes, Oncology, Infectious Diseases, Autoimmune Disease, and Others), End-users (Hospitals and Clinics, Diagnostics Laboratories, and Others) |
|
Regional Scope |
Netherlands |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott Laboratories; Danaher Corporation; F.Hoffmann-La Roche AG; Bio-Rad Laboratories Inc.; and Thermo Fisher Scientific Inc. |
Market Segment Insights:
Immuno diagnostics segment is projected to account for a large market share
Based on test types, the Netherlands in-vitro diagnostics market is divided into clinical chemistry, haematology, immuno diagnostics, molecular diagnostics, and others. The immuno diagnostics segment is projected to constitute a key share of the market during the forecast period due to growing demand for detecting the infectious microbes including bacteria, viruses, and fungus with the help of toxin detection. Immuno diagnostics is mainly has its accuracy for detection of the diseases. On the other hand, the clinical chemistry segment is expected to expand at a rapid pace in the coming years owing to practical applying of biochemistry and highly used for body fluid analyzing for diagnostics and therapeutic purposes.
Reagents segment is projected to hold a key market share
On the basis of Products, the market is segmented into reagents, instruments, and others. The reagents segment is expected to represent a key share of the market during the forecast period owing to accurate, rapid and sensitive devices. Increasing demand for point of care products & self testing, high usage in in-vitro diagnostic testing, and increase in the R&D initiatives related to reagents are anticipated to boost the market.
Disposable IVD devices segment is projected to constitute a major market share
In terms of usability, the Netherlands in-vitro diagnostics market is segregated into reusable IVD devices and disposable IVD devices. The disposable IVD devices segment is expected to account for a key share of the market during the forecast period owing to increasing environmental effects and growing safety issues among people.
Infectious diseases segment is projected to hold a key market share
On the basis of applications, the market is segmented into cardiology, diabetes, oncology, infectious diseases, autoimmune disease, and others. The infectious diseases segment is anticipated to hold a key share of the market during the forecast period owing to increase in incidences of hepatitis, pneumonia, HIV-AIDS, tuberculosis, and others. Development of infectious diseases detection assays by key players for in vitro diagnostics is estimated to fuel the market.
Hospital and clinics segment is projected to account for a large market share
Based on end-users, the Netherlands in-vitro diagnostics market is divided into hospitals and clinics, diagnostics laboratories, and others. The hospitals and clinics segment is expected to account for a key share of the market during forecast period to rise in hospitalization as doctors need diagnostics interpretation for further treatment. The development of hospital infrastructure to increase the hospital facilities is expected to drive the market. However, the diagnostics laboratories segment is anticipated to expand at a rapid pace in the coming years owing to it operates in collaboration of hospitals.
Segments
Segments Covered in the Report
The Netherlands in-vitro diagnostics market has been segmented on the basis of
Test Types
- Clinical Chemistry
- Haematology
- Immuno Diagnostics
- Molecular Diagnostics
- Others
Products
- Reagents
- Instruments
- Others
Usability
- Reusable IVD Devices
- Disposable IVD Devices
Applications
- Cardiology
- Diabetes
- Oncology
- Infectious Diseases
- Autoimmune Disease
- Others
End-users
- Hospitals and Clinics
- Diagnostics Laboratories
- Others
Country
- Netherlands
Key Players
- Abbott Laboratories
- Danaher Corporation
- F.Hoffmann-La Roche AG
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
Competitive Landscape
Key players competing in the Netherlands in-vitro diagnostics market include Abbott Laboratories; Danaher Corporation; F.Hoffmann-La Roche AG; Bio-Rad Laboratories Inc.; and Thermo Fisher Scientific Inc. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-vitro Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In-vitro Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In-vitro Diagnostics Market - Supply Chain
4.5. Global In-vitro Diagnostics Market Forecast
4.5.1. In-vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In-vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. In-vitro Diagnostics Market Absolute $ Opportunity
5. Global In-vitro Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. In-vitro Diagnostics Market Size and Volume Forecast by Types
5.3.1. Clinical Chemistry
5.3.2. Haematology
5.3.3. Immuno Diagnostics
5.3.4. Molecular Diagnostics
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global In-vitro Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. In-vitro Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global In-vitro Diagnostics Demand Share Forecast, 2019-2026
7. North America In-vitro Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America In-vitro Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America In-vitro Diagnostics Market Size and Volume Forecast by Types
7.4.1. Clinical Chemistry
7.4.2. Haematology
7.4.3. Immuno Diagnostics
7.4.4. Molecular Diagnostics
7.4.5. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America In-vitro Diagnostics Demand Share Forecast, 2019-2026
8. Latin America In-vitro Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America In-vitro Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America In-vitro Diagnostics Market Size and Volume Forecast by Types
8.4.1. Clinical Chemistry
8.4.2. Haematology
8.4.3. Immuno Diagnostics
8.4.4. Molecular Diagnostics
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America In-vitro Diagnostics Demand Share Forecast, 2019-2026
9. Europe In-vitro Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe In-vitro Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe In-vitro Diagnostics Market Size and Volume Forecast by Types
9.4.1. Clinical Chemistry
9.4.2. Haematology
9.4.3. Immuno Diagnostics
9.4.4. Molecular Diagnostics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe In-vitro Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific In-vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific In-vitro Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific In-vitro Diagnostics Market Size and Volume Forecast by Types
10.4.1. Clinical Chemistry
10.4.2. Haematology
10.4.3. Immuno Diagnostics
10.4.4. Molecular Diagnostics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific In-vitro Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa In-vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa In-vitro Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa In-vitro Diagnostics Market Size and Volume Forecast by Types
11.4.1. Clinical Chemistry
11.4.2. Haematology
11.4.3. Immuno Diagnostics
11.4.4. Molecular Diagnostics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa In-vitro Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global In-vitro Diagnostics Market: Market Share Analysis
12.2. In-vitro Diagnostics Distributors and Customers
12.3. In-vitro Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott Laboratories
12.4.2. Danaher Corporation
12.4.3. F.Hoffmann-La Roche AG
12.4.4. Bio-Rad Laboratories Inc.
12.4.5. Thermo Fisher Scientific Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-vitro Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. In-vitro Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. In-vitro Diagnostics Market - Supply Chain
4.5. Global In-vitro Diagnostics Market Forecast
4.5.1. In-vitro Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. In-vitro Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. In-vitro Diagnostics Market Absolute $ Opportunity
5. Global In-vitro Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. In-vitro Diagnostics Market Size and Volume Forecast by Types
5.3.1. Clinical Chemistry
5.3.2. Haematology
5.3.3. Immuno Diagnostics
5.3.4. Molecular Diagnostics
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global In-vitro Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. In-vitro Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global In-vitro Diagnostics Demand Share Forecast, 2019-2026
7. North America In-vitro Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America In-vitro Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America In-vitro Diagnostics Market Size and Volume Forecast by Types
7.4.1. Clinical Chemistry
7.4.2. Haematology
7.4.3. Immuno Diagnostics
7.4.4. Molecular Diagnostics
7.4.5. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America In-vitro Diagnostics Demand Share Forecast, 2019-2026
8. Latin America In-vitro Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America In-vitro Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America In-vitro Diagnostics Market Size and Volume Forecast by Types
8.4.1. Clinical Chemistry
8.4.2. Haematology
8.4.3. Immuno Diagnostics
8.4.4. Molecular Diagnostics
8.4.5. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America In-vitro Diagnostics Demand Share Forecast, 2019-2026
9. Europe In-vitro Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe In-vitro Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe In-vitro Diagnostics Market Size and Volume Forecast by Types
9.4.1. Clinical Chemistry
9.4.2. Haematology
9.4.3. Immuno Diagnostics
9.4.4. Molecular Diagnostics
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe In-vitro Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific In-vitro Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific In-vitro Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific In-vitro Diagnostics Market Size and Volume Forecast by Types
10.4.1. Clinical Chemistry
10.4.2. Haematology
10.4.3. Immuno Diagnostics
10.4.4. Molecular Diagnostics
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific In-vitro Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa In-vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa In-vitro Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa In-vitro Diagnostics Market Size and Volume Forecast by Types
11.4.1. Clinical Chemistry
11.4.2. Haematology
11.4.3. Immuno Diagnostics
11.4.4. Molecular Diagnostics
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa In-vitro Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global In-vitro Diagnostics Market: Market Share Analysis
12.2. In-vitro Diagnostics Distributors and Customers
12.3. In-vitro Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott Laboratories
12.4.2. Danaher Corporation
12.4.3. F.Hoffmann-La Roche AG
12.4.4. Bio-Rad Laboratories Inc.
12.4.5. Thermo Fisher Scientific Inc.
Segments Covered in the Report
The Netherlands in-vitro diagnostics market has been segmented on the basis of
Test Types
- Clinical Chemistry
- Haematology
- Immuno Diagnostics
- Molecular Diagnostics
- Others
Products
- Reagents
- Instruments
- Others
Usability
- Reusable IVD Devices
- Disposable IVD Devices
Applications
- Cardiology
- Diabetes
- Oncology
- Infectious Diseases
- Autoimmune Disease
- Others
End-users
- Hospitals and Clinics
- Diagnostics Laboratories
- Others
Country
- Netherlands
Key Players
- Abbott Laboratories
- Danaher Corporation
- F.Hoffmann-La Roche AG
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
Key players competing in the Netherlands in-vitro diagnostics market include Abbott Laboratories; Danaher Corporation; F.Hoffmann-La Roche AG; Bio-Rad Laboratories Inc.; and Thermo Fisher Scientific Inc. Some of these players are engaged in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.
Our Clients
Related Reports
Some other reports from this category!
